These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3754656)

  • 41. Pirenzepine: a selective anticholinergic for peptic ulcer.
    Drug Ther Bull; 1985 Apr; 23(8):29-31. PubMed ID: 3888582
    [No Abstract]   [Full Text] [Related]  

  • 42. Pirenzepine in peptic ulcer. Introduction to clinical trials reports.
    Chierichetti SM; Gaetani M; Petrin G
    Scand J Gastroenterol Suppl; 1979; 57():7-10. PubMed ID: 396661
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pirenzepine in gastric and duodenal ulcer: randomized comparison with cimetidine].
    Bayeli PF; Benelli R
    Clin Ter; 1982 Jul; 102(2):139-52. PubMed ID: 6754216
    [No Abstract]   [Full Text] [Related]  

  • 44. [Acid and gastrin secretion before and after treatment with pirenzepine in patients with duodenal ulcer].
    Sternini C; Tomassetti P; Bonora G; Ferri GL; Botti PL; Vezzadini P
    Minerva Dietol Gastroenterol; 1982; 28(1):59-64. PubMed ID: 6896230
    [No Abstract]   [Full Text] [Related]  

  • 45. Sucralfate, bismuth compounds, substituted benzimidazoles, trimipramine and pirenzepine in the short- and long-term treatment of duodenal ulcer.
    Tytgat GN; Hameeteman W; van Olffen GH
    Clin Gastroenterol; 1984 May; 13(2):543-68. PubMed ID: 6378446
    [No Abstract]   [Full Text] [Related]  

  • 46. [A comparative evaluation of the action of kvamatel and omez on the glutathione system in different sections of the digestive system in experimental duodenal ulcer].
    Daminov ShN; Inoiatova FKh
    Eksp Klin Farmakol; 1998; 61(4):26-8. PubMed ID: 9783104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effects of traditional antiulcer therapy on the motor-secretory function and microcirculation in the gastric and duodenal wall in patients with duodenal ulcer].
    Orlov VA; Shamkhalov ZM; Pugaeva NR
    Klin Med (Mosk); 1995; 73(4):96. PubMed ID: 7474844
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of fats on the emptying function of the gastric stump and small intestine in patients after gastrectomy by the Billroth II method].
    Saakia AR; Dobzhanidze DN
    Ter Arkh; 1989; 61(2):49-51. PubMed ID: 2727920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Mechanism of action of the gastric secretion inhibitor Pirenzepin].
    Hammer R; Koss FW
    Fortschr Med; 1980 Apr; 98(14):(549-54). PubMed ID: 6892811
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment and prevention of recurrence of duodenal ulcer with pirenzepin and cimetidine].
    Eichenberger PM; Giger M; Mattle W; Pelloni S; Müller-Lissner SA; Gonvers JJ; Birchler R; Blum AL
    Schweiz Med Wochenschr; 1982 Jan; 112(1):25-30. PubMed ID: 7036336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Depressive effect of intraduodenal administration of hydrochloric acid on the evacuatory function and bioelectrical potential of the stomach in peptic ulcer with localization in the duodenal bulb].
    Sibirkin NV; Kuziaev AI; Bat'ko VP
    Ter Arkh; 1978; 50(2):8-9. PubMed ID: 644498
    [No Abstract]   [Full Text] [Related]  

  • 52. [Our experience in the use of gastric secretion inhibitors in surgery].
    Catrambone G; Ferraris R; Parodi A; Ruffo A
    Minerva Med; 1981 Nov; 72(45):2999-3002. PubMed ID: 6895545
    [No Abstract]   [Full Text] [Related]  

  • 53. A combination of pirenzepine and cimetidine: a new approach to treatment of duodenal ulcer in "non-responders".
    Dal Monte PR; D'Imperio M; Ferri M; Fratucello F; del Soldato P
    Hepatogastroenterology; 1985 Jun; 32(3):126-8. PubMed ID: 3839484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Agents with tricyclic structures for treating peptic ulcer disease.
    Berardi RR; Caplan NB
    Clin Pharm; 1983; 2(5):425-31. PubMed ID: 6354568
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pirenzepine given parenterally in gastroduodenopathies in patients with medico-surgical emergencies].
    Mazzarella B; Mastronardi P; Macarone Palmieri A; Lettieri B; Lo Schiavo F; Valentini P
    Minerva Dietol Gastroenterol; 1984; 30(3):221-6. PubMed ID: 6334247
    [No Abstract]   [Full Text] [Related]  

  • 56. [Characteristics of the motor function of the proximal segment of the gastrointestinal tract].
    Virchenko SB; Kucherenko TL
    Fiziol Zh (1978); 1989; 35(3):32-8. PubMed ID: 2737325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of pirenzepine in peptic ulcer and in non ulcerous gastroduodenal diseases. A multicentre controlled clinical trial.
    Giorgi-Conciato M; Daniotti S; Ferrari PA; Gaetani M; Petrin G; Sala P; Valentini P
    Scand J Gastroenterol Suppl; 1982; 81():1-41. PubMed ID: 6221398
    [No Abstract]   [Full Text] [Related]  

  • 58. Anticholinergic action of pirenzepine (Gastrozepin) on isolated gastrointestinal tract smooth muscles.
    Ojewole JA
    Methods Find Exp Clin Pharmacol; 1983; 5(3):171-5. PubMed ID: 6688455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of pirenzepin on the pH of the gastric content and on basal acid secretion and on that stimulated by betazole, in patients with duodenal ulcer].
    Ribeiro Tde C; Coelho LG; Avelar CD; Castro Lde P
    AMB Rev Assoc Med Bras; 1984; 30(5-6):105-7. PubMed ID: 6333050
    [No Abstract]   [Full Text] [Related]  

  • 60. [Receptor characteristics of the duodenal mucosa in peptic ulcer: a new approach to the individual selection of the therapy].
    Pavlov SA; Vinogradov VA; Iarygin KN; Shugurov VA; Bogdanov AN
    Ter Arkh; 1989; 61(2):24-7. PubMed ID: 2543094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.